Swara Baby Files DRHP for ₹1,000 Crore IPO to Fuel Expansion

Swara Baby, India’s leading contract manufacturer of disposable hygiene products, has officially filed its Draft Red Herring Prospectus (DRHP) with SEBI to launch a ₹1,000 crore initial public offering. The move signals the company's intent to scale its manufacturing footprint and strengthen its position in the rapidly growing hygiene segment.

IPO Structure and Fund Utilization

The proposed ₹1,000 crore IPO is split equally between a fresh issue of equity shares worth up to ₹500 crore and an Offer for Sale (OFS) of up to ₹500 crore. Within the OFS component, Brainbees Solutions Limited will sell shares worth up to ₹300 crore, while Anadya Bon Merchari LLP will divest up to ₹200 crore.

Swara Baby has outlined a strategic roadmap for the fresh issue proceeds. A significant portion, totaling ₹198.2 crore, is earmarked for establishing a new manufacturing facility in Madhya Pradesh. Additionally, the company plans to utilize ₹100 crore to repay or prepay existing borrowings and ₹27.5 crore to settle debt within its subsidiaries—Solis Hygiene, Swara Hygiene, and K.A. Enterprises Hygiene Private Limited (KAEHPL). The remaining funds will be directed toward inorganic growth via acquisitions and general corporate purposes.

Market Leadership and Manufacturing Prowess

Since its inception in 2018, Swara Baby has emerged as a dominant force in the contract manufacturing space. In FY25, the company held a commanding 37% market share by value in the baby diaper segment and a 36% share in the adult diaper segment.

The company currently operates four manufacturing facilities across 24 acres in Pithampur and Indore, Madhya Pradesh. Its massive production capacity includes approximately 2.66 billion baby diapers, 253 million adult diapers/period panties, and 756 million sanitary napkins and liners annually. Beyond contract manufacturing for giants like Himalaya Wellness Company and Piramal Pharma, the company also operates its own consumer brands, including 'Cuddles' for baby diapers and 'Shield' for adult incontinence.

Robust Financial Performance and Growth Trajectory

The company’s financial health shows a consistent upward trend. In FY26, Swara Baby reported revenue from operations of ₹1,163.9 crore, a notable jump from ₹942.97 crore in FY25 and ₹749.96 crore in FY24. Profit After Tax (PAT) also saw an increase, rising to ₹95.58 crore in FY26 from ₹80.67 crore in the previous fiscal year.

The product mix is heavily driven by the baby care segment, which accounted for 79.06% of total product sales in FY26, generating ₹911.81 crore. Adult incontinence products followed with 16.07% of revenue, while feminine hygiene contributed 2.72%. With the Indian hygiene market projected to grow at a CAGR of 12.7%, Swara Baby is positioning itself to capture long-term value through innovation, such as its patent-pending plant-based "Tree Free" diaper.

Key Takeaways

  • Strategic Expansion: The ₹1,000 crore IPO will primarily fund a new manufacturing unit in Madhya Pradesh (₹198.2 crore) and debt repayment.
  • Market Dominance: Swara Baby holds a massive market share in contract manufacturing, leading the baby diaper segment with 37% and adult diapers with 36%.
  • Strong Financial Momentum: The company has demonstrated consistent revenue growth, reaching ₹1,163.9 crore in FY26 with a rising PAT of ₹95.58 crore.